Product Name: 4-Amino-3-methoxybenzoic acid
CAS RN: 2486-69-3
ChemMol ID: 44007393
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186052
Structure:
Product Name: 4-Amino-3-hydroxybenzoic acid
CAS RN: 2374-03-0
ChemMol ID: 44007392
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186051
Structure:
Product Name: 2-Chloro-4-methoxybenzoic acid
CAS RN: 21971-21-1
ChemMol ID: 44007391
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186050
Structure:
Product Name: 2-Amino-4-methylbenzonitrile
CAS RN: 26830-96-6
ChemMol ID: 44007390
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186049
Structure:
Product Name: 2-Amino-4-methylbenzoic acid
CAS RN: 2305-36-4
ChemMol ID: 44007389
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186048
Structure:
Product Name: 2-Amino-4-methoxybenzothiazole
CAS RN: 5464-79-9
ChemMol ID: 44007388
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186047
Structure:
Product Name: 2,3-Diaminobenzoic acid
CAS RN: 603-81-6
ChemMol ID: 44007386
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186045
Structure:
Product Name: 2-Amino-3-nitrophenol
CAS RN: 603-85-0
ChemMol ID: 44007387
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186046
Structure:
Product Name: 2-(3-chlorophenyl)oxirane
CAS RN: 20697-04-5
ChemMol ID: 44007385
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186044
Structure:
Product Name: 2-Bromo-5-chloro-benzoic acid
CAS RN: 21739-93-5
ChemMol ID: 44007384
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186043
Structure:
Product Name: 1-Iodo-3-trifluoromethoxy-benzene
CAS RN: 198206-33-6
ChemMol ID: 44007383
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186042
Structure:
Product Name: (R)-4-phenyl-2-oxazolidinone
CAS RN: 90319-52-1
ChemMol ID: 44007382
Supplier: BEYOND PHARMATECH CORPORATION LIMITED
Supplier Products ID: B186041
Structure:
No comments:
Post a Comment